Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Humacyte to go public via SPAC

By Brian Buntz | August 24, 2021

HumacyteThe biotech platform company Humacyte is merging with Alpha Healthcare Acquisition Corp. (NSDQ:AHAC) (“AHAC”), a special purpose acquisition company (SPAC).

AHAC’s shareholders approved the deal today and plan to submit results from the meeting to the SEC via a Form 8-K document.

The two organizations expect the merger to finalize on August 26 and stock shares to begin trading under the tickers “HUMA” and “HUMAW” a day later.

Based in Durham, N.C., Humacyte specializes in implantable bioengineered human tissues and organs, including acellular tissues for treating various ailments.

The company’s first product candidate, known as HAV, includes vascular cells on a polymer mesh that eventually form a cylindrical vessel structure. HAV is the first product to receive Regenerative Medicine Advanced Therapy (RMAT) designation from FDA. It has also received FDA fast track designation.

Former Duke University professor Laura Niklason and Duke University alumni Shannon Dahl and Juliana Blum founded Humacyte in 2004.

Alpha Healthcare Acquisition Corp. first reached a definitive agreement to merge with Humacyte in February 2021.

AHAC went public in late July.


Filed Under: clinical trials, Drug Discovery
Tagged With: Alpha Healthcare Acquisition Corp., Humacyte, SPAC, special purpose acquisition company
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

lab microscope
Accelerating R&D with FAIR data
Kallyope
Kallyope’s focus on the gut-brain axis yields a diverse portfolio
Axcella
Axcella touts positive results from Phase 2a long COVID study
artificial intelligence
Defining complexity: A framework to identify complex clinical trials and set them up for success

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50